Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

BIIB

BIOGEN INC.

CIK 0000875045 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$198.91
↓ 1.45 (-0.72%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership, Technicals, Options

Key stats

Market Cap
$29.37B
P/E Ratio
21.41
EPS
8.83
Dividend Yield
Not covered
52W Position
79%
Beta
0.30

Valuation multiples

Fwd P/E
15.48
PEG
4.55
P/B
1.57
P/S
2.96
EV/Revenue
3.59
ROE
7.4%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 79%
$121.05$219.72

Latest Financials

2025-12-31 FY
Revenue
$9.89B
Net Income
$1.29B
Total Assets
$29.44B
Free Cash Flow
$2.05B

Recent news